by admin_63069 | Jun 12, 2024 | News You Can Use
Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.
by admin_63069 | Jun 10, 2024 | Related Topics
Intensity-modulated radiation therapy (IMRT) — which is a common radiation strategy for men with prostate cancer — has changed and improved over the last two decades.
by admin_63069 | Jun 5, 2024 | News You Can Use
Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study.
by admin_63069 | Jun 3, 2024 | Related Topics
New therapies being developed are moving into earlier lines of therapy, with the idea that most patients with early-stage prostate cancer will progress and need additional therapy later.
by admin_63069 | May 29, 2024 | News You Can Use
Hope for the future of prostate cancer treatment: the possibility of immune memory
